Fiduciary Trust’s Merck MRK Stock Holding History

Fiduciary Trust’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.9M	Sell	406,382 -17,514	-4%	-$2.02M	0.58%	32
2025 Q4	$44.6M	Sell	423,896 -8,147	-2%	-$765K	0.51%	38
2025 Q3	$36.3M	Buy	432,043 +2,774	+0.6%	+$228K	0.41%	43
2025 Q2	$34M	Sell	429,269 -19,910	-4%	-$1.58M	0.42%	40
2025 Q1	$40.3M	Buy	449,179 +33,280	+8%	+$3.11M	0.53%	36
2024 Q4	$41.4M	Sell	415,899 -13,344	-3%	-$1.38M	0.55%	35
2024 Q3	$48.7M	Buy	429,243 +16,322	+4%	+$1.94M	0.68%	30
2024 Q2	$51.1M	Buy	412,921 +3,421	+0.8%	+$441K	0.77%	26
2024 Q1	$54M	Buy	409,500 +2,742	+0.7%	+$338K	0.83%	21
2023 Q4	$44.3M	Buy	406,758 +6,034	+2%	+$626K	0.74%	28
2023 Q3	$41.3M	Sell	400,724 -12,184	-3%	-$1.31M	0.75%	26
2023 Q2	$47.6M	Sell	412,908 -1,698	-0.4%	-$193K	0.84%	21
2023 Q1	$44.1M	Sell	414,606 -5,020	-1%	-$542K	0.82%	23
2022 Q4	$46.6M	Sell	419,626 -4,285	-1%	-$438K	0.91%	20
2022 Q3	$36.5M	Sell	423,911 -3,679	-0.9%	-$328K	0.79%	23
2022 Q2	$39M	Buy	427,590 +1,627	+0.4%	+$144K	0.82%	22
2022 Q1	$35M	Sell	425,963 -4,023	-0.9%	-$317K	0.63%	30
2021 Q4	$33M	Sell	429,986 -1,629	-0.4%	-$130K	0.54%	37
2021 Q3	$32.4M	Sell	431,615 -3,285	-0.8%	-$250K	0.58%	31
2021 Q2	$33.8M	Sell	434,900 -33,012	-7%	-$2.46M	0.65%	31
2021 Q1	$34.4M	Sell	467,912 -9,549	-2%	-$704K	0.7%	28
2020 Q4	$37.3M	Sell	477,461 -2,682	-0.6%	-$205K	0.78%	24
2020 Q3	$38M	Buy	480,143 +444	+0.1%	+$34.8K	0.9%	21
2020 Q2	$35.4M	Sell	479,699 -2,749	-0.6%	-$207K	0.88%	20
2020 Q1	$35.4M	Buy	482,448 +614	+0.1%	+$48.3K	1.03%	19
2019 Q4	$41.8M	Buy	481,834 +1,600	+0.3%	+$131K	0.98%	22
2019 Q3	$38.6M	Buy	480,234 +12,579	+3%	+$1.01M	0.97%	21
2019 Q2	$37.4M	Buy	467,655 +11,768	+3%	+$901K	0.98%	21
2019 Q1	$36.2M	Sell	455,887 -6,354	-1%	-$475K	0.97%	23
2018 Q4	$33.7M	Sell	462,241 -15,446	-3%	-$1.09M	1.03%	22
2018 Q3	$32.3M	Sell	477,687 -5,419	-1%	-$345K	0.91%	24
2018 Q2	$28M	Sell	483,106 -5,997	-1%	-$338K	0.85%	28
2018 Q1	$25.4M	Buy	489,103 +23,836	+5%	+$1.29M	0.79%	32
2017 Q4	$25M	Sell	465,267 -20,647	-4%	-$1.14M	0.74%	40
2017 Q3	$29.7M	Buy	485,914 +5,426	+1%	+$329K	0.91%	27
2017 Q2	$29.4M	Buy	480,488 +29,228	+6%	+$1.78M	0.9%	28
2017 Q1	$27.4M	Buy	451,260 +9,259	+2%	+$562K	0.84%	27
2016 Q4	$24.8M	Buy	442,001 +4,992	+1%	+$292K	0.8%	31
2016 Q3	$26M	Buy	437,009 +4,805	+1%	+$281K	0.89%	26
2016 Q2	$23.8M	Buy	432,204 +3,554	+0.8%	+$189K	0.83%	30
2016 Q1	$21.6M	Buy	428,650 +20,768	+5%	+$1.02M	0.77%	35
2015 Q4	$30.6M	Sell	407,882 -4,268	-1%	-$215K	1.3%	20
2015 Q3	$19.4M	Buy	412,150 +12,342	+3%	+$656K	0.88%	34
2015 Q2	$21.7M	Buy	399,808 +24,789	+7%	+$1.39M	0.9%	33
2015 Q1	$20.6M	Sell	375,019 -3,586	-0.9%	-$203K	0.85%	35
2014 Q4	$20.5M	Buy	378,605 +780	+0.2%	+$43.5K	0.86%	38
2014 Q3	$21.4M	Sell	377,825 -7,331	-2%	-$412K	0.94%	33
2014 Q2	$21.3M	Sell	385,156 -13,381	-3%	-$730K	0.91%	33
2014 Q1	$21.6M	Sell	398,537 -9,016	-2%	-$467K	0.96%	32
2013 Q4	$19.5M	Sell	407,553 -15,098	-4%	-$690K	0.86%	37
2013 Q3	$19.2M	Buy	422,651 +7	+0%	+$320	0.88%	33
2013 Q2	$18.7M	Buy	+422,644	New	+$18.9M	0.87%	34

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fiduciary Trust's MRK Position: Q1 2026 in Review

Fiduciary Trust reduced its Merck (MRK) stake by 4.1% in Q1 2026, selling an estimated $2.02M and leaving 406,382 shares worth $48.9M. The position accounts for 0.58% of the portfolio, ranked #32.

Fiduciary Trust first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $54M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Fiduciary Trust held 406,382 shares of Merck worth $48.9M as of Q1 2026.
Fiduciary Trust sold 17,514 Merck shares in Q1 2026, an estimated $2.02M.
Merck made up 0.58% of Fiduciary Trust's portfolio in Q1 2026, its #32 holding.
Fiduciary Trust first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Fiduciary Trust's Merck position peaked at $54M in Q1 2024.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.